
Publication|Articles|January 1, 2025
- Optimizing Delivery of Nimodipine in Patients With Subarachnoid Hemorrhage
Optimizing Delivery of Nimodipine in Patients With Subarachnoid Hemorrhage
Author(s)Azurity Pharmaceuticals
Key Takeaways
- Personalized treatment strategies are crucial in managing lung cancer brain metastases, integrating targeted therapies and immunotherapies for improved outcomes.
- Stereotactic radiosurgery and whole-brain radiotherapy are evolving with novel systemic therapies, offering less invasive options.
This article is sponsored by Azurity Pharmaceuticals, Inc.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months
2
Navigating REMS: Challenges, Perspectives, and the Path Forward for Bispecific Antibody Programs
3
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
4
Building a Pharmacist-Led Furoscix Workflow From Scratch
5


































































































